Table 3.
Complete response | Partial response | Stable disease | Disease progression | Total (%) | |
---|---|---|---|---|---|
AC |
34 (18.8%) |
29 (16.9%) |
16 (9.5%) |
7 (4.1%) |
86 (49.3) |
CAF |
16 (8.8%) |
11 (6.5%) |
11 (6.5%) |
6 (3.5%) |
44 (25.3) |
CMF |
4 (2.3%) |
5 (2.9%) |
- |
2 (1.2%) |
11 (6.4) |
Others. |
9 (5.0%) |
11 (6.5%) |
5 (2.9%) |
8 (4.6%) |
33 (19.0) |
Total (%) | 63 (34.9%) | 56 (32.8%) | 32 (18.9%) | 23 (13.4%) | 174 (100) |
A, Adriamycin; C, Cyclophosphamide; F, 5-Fluorouracil; M, Methotrexate.